Lauren L. Ritterhouse

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer

Justin F. Gainor, Leila Dardaei, Satoshi Yoda et al. · Cancer Discovery · 2016 · 1.1K citations · Full text

Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

Brooke E. Howitt, Sachet A. Shukla, Lynette M. Sholl et al. · JAMA Oncology · 2015 · 666 citations · Full text

Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer

Kyle C. Strickland, Brooke E. Howitt, Sachet A. Shukla et al. · Oncotarget · 2016 · 612 citations · Full text

Neoantigen Load, Brca1/2-mutation Status, Cancer Immunosurveillance +15

Institutional implementation of clinical tumor profiling on an unselected cancer population

Lynette M. Sholl, T. Khanh, Priyanka Shivdasani et al. · JCI Insight · 2016 · 434 citations · Full text

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Sara M. Tolaney, Hao Guo, Sònia Pernas et al. · Journal of Clinical Oncology · 2019 · 276 citations · Full text